Pay in 4 interest-free payments of $5.62 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
N-(4-tertiarybutylphenyl)-4-(3-chloropyridin-2-yl)tetrahydropyrazine -1(2H)-carbox-amide (BCTC), a novel, orally effective vanilloid receptor 1 antagonist with analgesic properties: I
1 3
Obese mouse models (Coskun 2022) show basal energy expenditure +8-12% vs vehicle, a major contributor to the magnitude of weight loss observed in phase II clinical trials
Increases Fullness: Helps you feel fuller faster, reducing overeating
For the scenario of "Currently Available Treatment," research data suggests Tirzepatide may be more relevant
Gnoni A, Longo S, Gnoni GV, Giudetti AM (2020) Carnitine in human muscle bioenergetics
